United States of America, with the exception of Mr. Piacentini,

who is citizen of Italy.

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

The information contained in Item 3 of the Original Filing is hereby

supplemented as follows:

On July 30, 2000, drugstore.com, entered into a Stock Purchase Agreement

(the "Common Stock Purchase Agreement") with Amazon.com and certain other

Purchasers (as defined therein) pursuant to which on August 4, 2000, Amazon.com

purchased 607,594 shares of Common Stock for $4.9375 per share, for an aggregate

purchase price of $2,999,995.37. On July 30, 2000, drugstore.com also issued to

Amazon.com an immediately exercisable warrant to purchase up to 2,500,000 shares

of drugstore.com's Common Stock at an exercise price of $4.9375 per share (the

"Warrant"). All of the funds used by Amazon.com to purchase the Common Stock

pursuant to the Common Stock Purchase Agreement were obtained from Amazon.com's

working capital. None of the funds used by Amazon.com to purchase the shares of

Common Stock consisted of funds or other consideration borrowed or otherwise

obtained for the purpose of acquiring, holding, trading or voting the shares of

Common Stock.

In addition, on July 30, 2000, drugstore.com also entered into a Stock

Purchase Agreement (the "Preferred Stock Purchase Agreement") with L. John Doerr

and certain other Purchasers (as defined therein) pursuant to which on August 4,

2000, Mr. Doerr purchased 10,126.58 shares of

Page 5 of 12

drugstore.com's Series 1 Preferred Stock, par value $.0001 per share (the

"Preferred Stock") at a price per share of $493.75, for an aggregate purchase

price of $4,999,998.87. Each share of Preferred Stock will be convertible into

100 shares of Common Stock upon the approval of drugstore.com's stockholders,

which approval may be obtained within 60 days of the date of hereof.

ITEM 4. PURPOSE OF TRANSACTION.

The information contained in Item 4 of the Original Filing is hereby

supplemented as follows:

Amazon.com acquired the Warrant and the Common Stock as a strategic

investment.

Amazon.com expects to evaluate on an ongoing basis drugstore.com's

financial condition, business operations and prospects, the market price of the

Common Stock, alternative investment opportunities, conditions in the securities

market generally and other factors. Accordingly, Amazon.com reserves the right

to change its plans and intentions at any time. Subject to compliance with

applicable laws, Amazon.com may, at any time and from time to time, acquire or

dispose of shares of Common Stock or other securities of drugstore.com pursuant

to public or private offerings or otherwise. To the knowledge of Amazon.com,

each of the directors and officers listed in Item 2 (as applicable) may make the

same evaluation and reserves the same rights.

Except as set forth above or as described in Item 6 of this Amendment

No.1 to Schedule 13D, neither Amazon.com nor, to the best of Amazon.com's

knowledge, any of the individuals named in Item 2 (as applicable), presently has

any plans or proposals that relate to or would result in any of the actions

specified in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.

The information contained in Item 5 of the Original Filing is hereby

amended as follows:

(a) (1) As of the date of this Amendment No. 1 to Schedule 13D,

Amazon.com beneficially owns 15,463,339 shares of Common Stock. Based on

68,276,897 shares of Common Stock outstanding as of August 4, 2000, (which

number includes (i) the 2,500,000 shares of Common Stock issuable upon exercise

of the Warrant which may be issued within 60 days of the date hereof and (ii)

the 4,593,989 shares of Common Stock which may be issued within 60 days of the

date hereof, if approved by the stockholders of drugstore.com, upon conversion

of the Preferred Stock), Amazon.com's beneficial ownership represents

approximately 22.6% of the total outstanding shares of Common Stock. Amazon.com

does not beneficially own any outstanding shares of Common Stock of

drugstore.com other than these 15,463,339 shares of Common Stock. The table

below summarizes the beneficial ownership of Amazon.com's directors and

executive officers:

AMAZON.COM DIRECTORS AND EXECUTIVE OFFICERS:

--------------------------------------------------------------------------------

NAME SHARES OF DRUGSTORE.COM COMMON STOCK BENEFICIALLY

OWNED

--------------------------------------------------------------------------------

Jeffrey P. Bezos 0

--------------------------------------------------------------------------------

Tom A. Alberg 0

--------------------------------------------------------------------------------

Page 6 of 12

--------------------------------------------------------------------------------

Scott D. Cook 0

--------------------------------------------------------------------------------

L. John Doerr 11,083,903(5)

--------------------------------------------------------------------------------

Patricia Q. Stonesifer 0

--------------------------------------------------------------------------------

Mark Britto 0

--------------------------------------------------------------------------------

Richard L. Dalzell 0

--------------------------------------------------------------------------------

Mark Peek 0

--------------------------------------------------------------------------------

Warren C. Jenson 0

--------------------------------------------------------------------------------

Diego Piacentini 0

--------------------------------------------------------------------------------

John D. Risher 0

--------------------------------------------------------------------------------

Jeffrey A. Wilke 0

--------------------------------------------------------------------------------

(2) As of the date of this Amendment No. 1 to Schedule 13D, L. John

Doerr beneficially owns 11,083,903 shares of Common Stock, including the shares

issuable upon conversion of the Preferred Stock. Based on 68,276,897 shares of

Common Stock outstanding as of August 4, 2000, (which number includes (i) the

2,500,000 shares of Common Stock issuable upon exercise of the Warrant which

may be issued within 60 days of the date hereof and (ii) the 4,593,989 shares of

Common Stock which may be issued within 60 days of the date hereof, if approved

by the stockholders of drugstore.com, upon conversion of the Preferred Stock),

Mr. Doerr's beneficial ownership represents approximately 16.2% of the total

outstanding shares of Common Stock. Mr. Doerr is not deemed to beneficially own

any outstanding

----------------

(5) Includes 6,313,633 shares of Common Stock held by Kleiner Perkins

Caufield & Byers VIII, L.P. ("KPCB VIII"), 365,600 shares of Common Stock held

by KPCB VIII Founders Fund, L.P., ("Founders Fund"), 351,538 shares of Common

Stock held by KPCB Life Sciences Zaibatsu Fund II, L.P. and 2,500 shares of

Common Stock held by KPCB IX Associates LLC. KPCB VIII and Founders Fund are

wholly controlled by KPCB VIII Associates, L.P. KPCB Life Sciences Zaibatsu Fund

II, L.P. is wholly controlled by KPCB VII Associates, L.P. As a general partner

of each of KPCB VIII Associates, L.P. and KPCB VII Associates, L.P., and as a

managing director of KPCB IX Associates LLC, Mr. Doerr may be deemed to

beneficially own the shares of Common Stock controlled by those entities. Mr.

Doerr disclaims beneficial ownership of the above shares of Common Stock except

to the extent of his pecuniary interest in the shares.

Also includes 28,715.7 shares of Preferred Stock held by KPCB VIII,

1,664.04 shares of Preferred Stock held by Founders Fund and 10,126.58 shares of

Preferred Stock held by Mr. Doerr personally. Upon the approval of

drugstore.com's stockholders, which approval may be obtained within 60 days of

the date hereof, each share of Preferred Stock will be convertible into 100

shares of Common Stock. Mr. Doerr disclaims beneficial ownership of the shares

of Preferred Stock held by KPCB VIII and Founders Fund, except to the extent of

his pecuniary interest in such entities.

Page 7 of 12

shares of Common Stock of drugstore.com other than these 11,083,903 shares of

Common Stock. With the exception of the 10,126.58 shares of Preferred Stock

purchased by Mr. Doerr in his individual capacity, Mr. Doerr disclaims

beneficial ownership of the shares of Common Stock and Preferred Stock held by

the funds affiliated with Kleiner Perkins Caufield & Byers, except to the extent

of his pecuniary interest in such entities. Amazon.com disclaims beneficial

ownership of all shares beneficially owned by any of its executive officers and

directors.

(b) (1) Amazon.com has the sole power to vote and to direct the vote of,

and the sole power to dispose of and to direct the disposition of, 15,463,339

shares of Common Stock.

(2) Mr. Doerr has (assuming the conversion of Mr. Doerr's

10,126.58 shares of Preferred Stock) the sole power to vote and to direct the

vote of, and the sole power to dispose and to direct the disposition of,

1,012,658 shares of Common Stock and, with certain funds affiliated with Kleiner

Perkins Caufield & Byers, shared voting power to vote and direct the vote of,

and shared power to dispose and direct the disposition of, 10,071,245 shares of

Common Stock.

(c) Except as described in Items 3 and 4 above, neither Amazon.com nor

any of its directors or executive officers has effected any transactions in the

Common Stock during the past 60 days.

(d) No other person is known to Amazon.com to have the right to receive

or the power to direct the receipt of dividends from, or the proceeds from the

sale of, the shares of Common Stock beneficially owned by Amazon.com on the date

of this Amendment No. 1 to Schedule 13D.

(e) Not applicable.

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO

SECURITIES OF THE ISSUER

The information contained in Item 6 of the Original Filing is hereby

supplemented as follows:

Under the terms of the Common Stock Purchase Agreement and the Preferred

Stock Purchase Agreement, drugstore.com has agreed to cause either (i) a special

meeting of its common stockholders within three months after August 4, 2000, for

the purpose of approving the conversion of the Preferred Stock into Common Stock

or (ii) the holders of the requisite number of shares of Common Stock to

deliver written consents approving the conversion of such Preferred Stock into

Common Stock. If drugstore.com fails to obtain the requisite stockholder

approval within three months after August 4, 2000, then drugstore.com is

obligated to repurchase all of the Preferred Stock at a price per share equal to

the then current market price of drugstore.com's Common Stock multiplied by the

number of shares of Common Stock into which one share of Preferred Stock would

have been convertible. Pursuant to the terms of a voting agreement between

drugstore.com and Amazon.com dated as of July 30, 2000 (the "Voting Agreement"),

Amazon.com agreed to vote its shares of Common Stock to approve the conversion

of the Preferred Stock. Mr. Doerr and Kleiner, Perkins, Caufield & Byers have

entered into similar voting agreements with respect to the conversion of the

Preferred Stock.

Page 8 of 12

Also pursuant to the terms of the Common Stock Purchase Agreement and

the Preferred Stock Purchase Agreement, drugstore.com has agreed to use its best

efforts to file a resale shelf registration statement (the "Registration

Statement") with, and within 60 days of August 4, 2000 have such Registration

Statement declared effective by, the Commission for purposes of registering the

resale of the Common Stock issued pursuant to the Common Stock Purchase

Agreement (and of the Common Stock issuable upon conversion of the Preferred

Stock issued pursuant to the Preferred Stock Purchase Agreement). drugstore.com

has further agreed to maintain the effectiveness of the Registration Statement

until the earlier of (i) the eighteen month anniversary of the effective date of

the Registration Statement and (ii) the date on which all shares of Common Stock

have been resold by the Purchasers.

In connection with Amazon.com's purchase of the Common Stock, Amazon.com

entered into an agreement with drugstore.com (the "Lock Up Agreement") with

respect to the transfer, sale or other disposition of any shares of drugstore's

Common Stock, including the shares purchased pursuant to the Common Stock

Purchase Agreement, held by Amazon.com such that Amazon.com will not, without

the prior written consent of drugstore.com and subject to certain exceptions,

during the period commencing July 30, 2000 and ending 180 days after the date of

the effectiveness of the Registration Statement, (1) offer, pledge, sell,

contract to sell, sell any option or contract to purchase, purchase any option

or contract to sell, grant any option, right or warrant to purchase, lend, or

otherwise transfer or dispose of, directly or indirectly, any shares of Common

Stock or any securities convertible into or exercisable or exchangeable for

Common Stock or (2) enter into any swap or other arrangement that transfers to

another, in whole or in part, any of the economic consequences of ownership of

Common Stock. Mr. Doerr and Kleiner, Perkins, Caufield & Byers have also each

entered into agreements that are similar to the Lock Up Agreement.

Page 9 of 12

10

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS

EXHIBIT

NUMBER

--------

1 Common Stock Purchase Agreement dated as of July 30, 2000 between

drugstore.com, Amazon.com and the other Purchasers (as defined

therein)

2. Preferred Stock Purchase Agreement dated as of July 30, 2000

between drugstore.com, L. John Doerr and the other Purchasers (as

defined therein)

3 Certificate of Designation of Series 1 Preferred Stock

4 Warrant for the Purchase of Shares of Common Stock

5 Lock Up Agreement dated as of July 30, 2000 between drugstore.com

and Amazon.com

6 Voting Agreement dated as of July 30, 2000 between drugstore.com

and Amazon.com

Page 10 of 12

11

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I

certify that the information set forth in this statement is true, complete and

correct.

August 16, 2000

------------------------------------

AMAZON.COM, INC.

/s/ MARK BRITTO

------------------------------------

By: Mark Britto

Title: Senior Vice President,

Marketing & Cross-Site

Merchandising

Page 11 of 12

12

EXHIBIT INDEX

EXHIBIT

NUMBER

-------

1. Common Stock Purchase Agreement dated as of July 30, 2000 between

drugstore.com, Amazon.com and the other Purchasers (as defined

therein)

2. Preferred Stock Purchase Agreement dated as of July 30, 2000

between drugstore.com, L. John Doerr and the other Purchasers (as

defined therein)

3 Certificate of Designation of Series 1 Preferred Stock

4 Warrant for the Purchase of Shares of Common Stock

5 Lock Up Agreement dated as of July 30, 2000 between drugstore.com

and Amazon.com

6 Voting Agreement dated as of July 30, 2000 between drugstore.com

and Amazon.com

Page 12 of 12